We are live on ! Find out more
GHA

GW Henssler & Associates Portfolio holdings

AUM $2.25B
1-Year Est. Return 19.46%
This Fund
S&P 500
This Quarter Est. Return
+8.43%
1 Year Est. Return
+19.46%
3 Year Est. Return
+62.37%
5 Year Est. Return
+80.78%
10 Year Est. Return
+246.91%
AUM
$1.77B
AUM Growth
+$106M
Cap. Flow
-$14.8M
Cap. Flow %
-0.83%
Top 10 Hldgs %
28.58%
Holding
222
New
53
Increased
66
Reduced
54
Closed
32

Top Buys

Rank Stock Value
1
EME icon
Emcor
EME
+$21.4M
2
TFC icon
Truist Financial
TFC
+$20.9M
3
HAS icon
Hasbro
HAS
+$16.3M
4
CRM icon
Salesforce
CRM
+$15.8M
5
ETR icon
Entergy
ETR
+$13M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$30.8M
2
KR icon
Kroger
KR
+$27.1M
3
PSX icon
Phillips 66
PSX
+$27M
4
MDT icon
Medtronic
MDT
+$21.5M
5
INGR icon
Ingredion
INGR
+$16.5M

Sector Composition

Rank Sector Weight
1 Technology 13.36%
2 Financials 11.23%
3 Utilities 10.21%
4 Healthcare 9.22%
5 Consumer Staples 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EME icon
26
Emcor
EME
$35.7B
$24.7M 1.4%
57,441
+56,580
+6,571% +$21.4M
ANET icon
27
Arista Networks
ANET
$242B
$24.3M 1.37%
252,976
+8,876
+4% +$773K
KO icon
28
Coca-Cola
KO
$374B
$23.3M 1.32%
324,531
-3,394
-1% -$232K
EVRG icon
29
Evergy
EVRG
$18.9B
$22.7M 1.28%
365,681
+6,879
+2% +$400K
V icon
30
Visa
V
$675B
$22.4M 1.27%
81,341
-720
-0.9% -$195K
LMT icon
31
Lockheed Martin
LMT
$139B
$22.2M 1.26%
37,957
-94
-0.2% -$50.5K
GD icon
32
General Dynamics
GD
$107B
$22M 1.25%
72,838
-551
-0.8% -$162K
ZBH icon
33
Zimmer Biomet
ZBH
$18.7B
$21.8M 1.23%
201,504
+218
+0.1% +$23.8K
AMT icon
34
American Tower
AMT
$78.8B
$21.7M 1.23%
93,350
-2,283
-2% -$506K
TFC icon
35
Truist Financial
TFC
$63.4B
$21.6M 1.22%
505,145
+494,007
+4,435% +$20.9M
AMZN icon
36
Amazon
AMZN
$3T
$21.5M 1.22%
115,399
-1,897
-2% -$346K
PEG icon
37
Public Service Enterprise Group
PEG
$37.2B
$21.1M 1.19%
236,437
-1,115
-0.5% -$89K
PEP icon
38
PepsiCo
PEP
$188B
$20.1M 1.14%
118,369
+1,373
+1% +$236K
TSCO icon
39
Tractor Supply
TSCO
$18B
$19.5M 1.1%
335,695
-4,805
-1% -$258K
AMCR icon
40
Amcor
AMCR
$21.8B
$19.3M 1.09%
341,345
+1,044
+0.3% +$55.4K
REGN icon
41
Regeneron Pharmaceuticals
REGN
$83.2B
$19M 1.07%
18,068
-477
-3% -$531K
MRK icon
42
Merck
MRK
$323B
$18.8M 1.06%
165,119
+1,183
+0.7% +$141K
CMCSA icon
43
Comcast
CMCSA
$89.4B
$18.6M 1.05%
445,371
+16,577
+4% +$654K
SCHW
44
Charles Schwab
SCHW
$187B
$18.5M 1.04%
284,917
+5,989
+2% +$393K
HAS icon
45
Hasbro
HAS
$13.3B
$18.2M 1.03%
+251,153
New +$16.3M
EMR icon
46
Emerson Electric
EMR
$88.5B
$18.1M 1.02%
165,553
+4,350
+3% +$468K
MO icon
47
Altria Group
MO
$109B
$17.6M 0.99%
344,531
+7,473
+2% +$378K
PFG icon
48
Principal Financial Group
PFG
$24.4B
$17.5M 0.99%
203,522
+1,197
+0.6% +$96.7K
CRM icon
49
Salesforce
CRM
$162B
$16.9M 0.96%
+61,807
New +$15.8M
GILD icon
50
Gilead Sciences
GILD
$165B
$16.3M 0.92%
194,548
-4,450
-2% -$340K

Similar funds

GW Henssler & Associates's Q3 2024 Portfolio in Review

As of Q3 2024, GW Henssler & Associates held 222 positions worth $1.77B, up 6.4% from $1.66B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

GW Henssler & Associates's Q3 2024 filing shows 53 new, 66 increased, 54 reduced and 32 closed positions. Its largest new stake was Hasbro: 251,153 shares worth $18.2M. The largest sale was GSK, an estimated $30.8M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Utilities.

  • GW Henssler & Associates's largest Q3 2024 buy was Hasbro: 251,153 shares worth $18.2M.
  • GW Henssler & Associates added most to Emcor in Q3 2024, an estimated $21.4M increase.
  • GW Henssler & Associates's biggest Q3 2024 reduction was GSK, cutting an estimated $30.8M.
  • GW Henssler & Associates fully exited Medtronic in Q3 2024, selling an estimated $21.5M.
  • GW Henssler & Associates's ten largest holdings make up 29% of its $1.77B portfolio in Q3 2024.
  • GW Henssler & Associates opened 53 new positions and closed 32 in Q3 2024.
  • GW Henssler & Associates's portfolio value rose 6.4% quarter-over-quarter to $1.77B.

Based on GW Henssler & Associates's 13F filing for Q3 2024, filed 25 Oct 2024.